HedgePath Pharmaceuticals Inc. announced that Richard J. Freer, Ph.D. has resigned effective August 13, 2013 as a director and/or officer of the company. Appointment of Directors and Officers. As part of the implementation of the plan and upon consummation of the transactions contemplated by the reincorporation merger and Contribution Agreement, the following persons were appointed as officers and directors: Frank E. O'Donnell, Jr., M.D as Executive Chairman and Director, Nicholas J. Virca as President, Chief Executive Officer and Director, Garrison J. Hasara, CPA as Chief Financial Officer, Secretary and Treasurer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0876 USD | -1.24% | -18.74% | -4.78% |
1st Jan change | Capi. | |
---|---|---|
-4.78% | 15.1M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- INTI Stock
- News Inhibitor Therapeutics, Inc.
- Hedgepath Pharmaceuticals, Inc. Announces Management Changes